234 related articles for article (PubMed ID: 36582063)
21. Overview of Alcohol Use Disorder.
Kranzler HR
Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
[TBL] [Abstract][Full Text] [Related]
22. Opioid antagonists for alcohol dependence.
Srisurapanont M; Jarusuraisin N
Cochrane Database Syst Rev; 2000; (3):CD001867. PubMed ID: 10908513
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
25. Advances in Pharmacotherapy Development: Human Clinical Studies.
Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
[TBL] [Abstract][Full Text] [Related]
26. Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review.
Sawicka M; Tracy DK
Ther Adv Psychopharmacol; 2017 Sep; 7(8-9):211-224. PubMed ID: 28959434
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.
McPheeters M; O'Connor EA; Riley S; Kennedy SM; Voisin C; Kuznacic K; Coffey CP; Edlund MD; Bobashev G; Jonas DE
JAMA; 2023 Nov; 330(17):1653-1665. PubMed ID: 37934220
[TBL] [Abstract][Full Text] [Related]
28. [The pharmacological treatment of PTSD and alcohol use disorder: a systematic literature review].
Neven A; de Jong J; Pieterse BH
Tijdschr Psychiatr; 2019; 61(10):692-701. PubMed ID: 31907913
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
Jonas DE; Amick HR; Feltner C; Bobashev G; Thomas K; Wines R; Kim MM; Shanahan E; Gass CE; Rowe CJ; Garbutt JC
JAMA; 2014 May; 311(18):1889-900. PubMed ID: 24825644
[TBL] [Abstract][Full Text] [Related]
31. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report.
Terasaki D; Ellinwood A; White D
Subst Abuse Treat Prev Policy; 2024 Feb; 19(1):18. PubMed ID: 38424567
[TBL] [Abstract][Full Text] [Related]
32. Opioid antagonists for alcohol dependence.
Srisurapanont M; Jarusuraisin N
Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
[TBL] [Abstract][Full Text] [Related]
33. Review of Evidence-Based Strategies to Treat Alcohol Use Disorder.
Worley J
J Psychosoc Nurs Ment Health Serv; 2021 Dec; 59(12):7-11. PubMed ID: 34846245
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
[TBL] [Abstract][Full Text] [Related]
35. Medication treatment for alcohol use disorder in special populations.
Malhotra A; Drexler K; Hsu M; Tang YL
Am J Addict; 2023 Sep; 32(5):433-441. PubMed ID: 37551638
[TBL] [Abstract][Full Text] [Related]
36. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
[No Abstract] [Full Text] [Related]
37. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis.
Bahji A; Bach P; Danilewitz M; Crockford D; Devoe DJ; El-Guebaly N; Saitz R
J Addict Med; 2022 Nov-Dec 01; 16(6):630-638. PubMed ID: 35653782
[TBL] [Abstract][Full Text] [Related]
38. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
[TBL] [Abstract][Full Text] [Related]
39. New pharmacotherapies for alcohol dependence.
Graham R; Wodak AD; Whelan G
Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
[TBL] [Abstract][Full Text] [Related]
40. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
